Cargando…
Acetazolamide treatment in late onset CDG type 1 due to biallelic pathogenic DHDDS variants
Pathogenic variants in DHDDS have been associated with either autosomal recessive retinitis pigmentosa or DHDDS-CDG. Heterozygous variants in DHDDS have been described in patients with a progressive neurodegenerative disease. Here we report on an individual presenting with a multisystem CDG phenotyp...
Autores principales: | Mousa, Jehan, Veres, Larissa, Mohamed, Anab, De Graef, Diederik, Morava, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421445/ https://www.ncbi.nlm.nih.gov/pubmed/36046393 http://dx.doi.org/10.1016/j.ymgmr.2022.100901 |
Ejemplares similares
-
CDG – an update
por: Morava, Eva, et al.
Publicado: (2011) -
A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity
por: Sabry, S., et al.
Publicado: (2016) -
Mannose treatment improves immune deficiency in mannose phosphate
isomerase–congenital disorder of glycosylation: case report and review of
literature
por: De Graef, Diederik, et al.
Publicado: (2022) -
How to find and diagnose a CDG due to defective N-glycosylation
por: Lefeber, Dirk J., et al.
Publicado: (2011) -
Adult‐onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS
por: Kim, Seondeuk, et al.
Publicado: (2021)